Publication | Closed Access

Long-term follow-up of CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation

Cell TherapyTransplantationMarrow TransplantationLong-term Follow-upStem Cell TransplantationImmunologyHematologyCell TransplantationAdult T-cell Leukemia-lymphomaImmunotherapyMedicineRadiation OncologyHealth Sciences